Fear of cancer recurrence in breast cancer survivors carrying a BRCA1/2 mutation: A qualitative study

被引:0
|
作者
Savard, Josee [1 ,2 ,3 ,8 ]
Filion, Catherine [2 ,3 ]
Brearty, Claudia Mc [1 ,2 ,3 ]
Caplette-Gingras, Aude [2 ,4 ]
Chiquette, Jocelyne [2 ,4 ,5 ]
Dorval, Michel [3 ,6 ,7 ]
机构
[1] Univ Laval, Sch Psychol, Quebec City, PQ, Canada
[2] Univ Laval, Ctr Rech, CHU Quebec, Quebec City, PQ, Canada
[3] Univ Laval, Canc Res Ctr, Quebec City, PQ, Canada
[4] Univ Laval, CHU Quebec, Ctr Maladies Sein, Quebec City, PQ, Canada
[5] Univ Laval, Fac Med, Quebec City, PQ, Canada
[6] Univ Laval, Fac Pharm, Quebec City, PQ, Canada
[7] CISSS Chaudiere Appalaches Res Ctr, Levis, PQ, Canada
[8] Univ Laval, Hop Enfant Jesus, Ctr integre cancerol, CHU Quebec, 1401 18e Rue, Quebec City, PQ G1J 1Z4, Canada
来源
CANCER MEDICINE | 2024年 / 13卷 / 01期
关键词
BRCA1/2 genetic mutation; breast cancer; fear of cancer recurrence; psychological intervention; qualitative study; RISK REDUCTION; THERAPY;
D O I
10.1002/cam4.6889
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundThere is preliminary evidence suggesting that FCR is a major problem for breast cancer survivors carrying a BRCA1/2 mutation. The goal of this qualitative study, conducted among women who were treated for breast cancer, was to provide a deeper understanding of how FCR is experienced in the context of a genetic predisposition to breast cancer.MethodThree focus groups (90-110 min) were conducted with 19 breast cancer survivors carrying a BRCA1/2 mutation. The semistructured interview probed FCR level and impact, the role FCR played in the decision to have a prophylactic bilateral mastectomy and/or salpingo-oophorectomy, the effect that surgery had on FCR, and the relevance of offering a psychological intervention targeting FCR to this population.ResultsFindings indicated that FCR was a significant issue in these women, even though a majority had undergone a prophylactic surgery. Patients strongly affirmed the need to develop and provide access to FCR interventions that are specifically adapted to the needs of this group.DiscussionThese results suggest that, although being the most effective medical option to reduce the actual risk of local recurrence (or second breast cancer), prophylactic surgery only partially reduces FCR. A psychological intervention targeting specifically FCR would be an appropriate complement to preventive surgery.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] A JAPANESE CASE OF BREAST CANCER WITH BRCA1 MUTATION
    Miwa, Noriko
    Nakamura, Seigo
    BREAST, 2011, 20 : S27 - S27
  • [22] Outcome of ovarian cancer after breast cancer in BRCA1 and BRCA2 mutation carriers
    Leendert H Zaaijer
    Helena C van Doorn
    Marian J E Mourits
    Marc van Beurden
    Joanne A de Hullu
    Muriel A Adank
    Luc R C W van Lonkhuijzen
    Hans F A Vasen
    Brigitte F M Slangen
    Katja N Gaarenstroom
    Ronald P Zweemer
    Peggy M L H Vencken
    Caroline Seynaeve
    Mieke Kriege
    British Journal of Cancer, 2016, 115 : 1174 - 1178
  • [23] A qualitative exploration of the fear of recurrence among Taiwanese breast cancer survivors
    Lai, Wei-Shu
    Shu, Bih-Ching
    Hou, Wen-Li
    EUROPEAN JOURNAL OF CANCER CARE, 2019, 28 (05)
  • [24] Outcome of ovarian cancer after breast cancer in BRCA1 and BRCA2 mutation carriers
    Zaaijer, Leendert H.
    van Doorn, Helena C.
    Mourits, Marian J. E.
    van Beurden, Marc
    de Hullu, Joanne A.
    Adank, Muriel A.
    van Lonkhuijzen, Luc R. C. W.
    Vasen, Hans F. A.
    Slangen, Brigitte F. M.
    Gaarenstroom, Katja N.
    Zweemer, Ronald P.
    Vencken, Peggy M. L. H.
    Seynaeve, Caroline
    Kriege, Mieke
    BRITISH JOURNAL OF CANCER, 2016, 115 (10) : 1174 - 1178
  • [25] A prospective study of breast cancer risk in relatives of BRCA1/BRCA2 mutation carriers
    Rowan, Erica
    Poll, Aletta
    Narod, Steven A.
    JOURNAL OF MEDICAL GENETICS, 2007, 44 (08)
  • [26] Population-Based Study of the Risk of Second Primary Contralateral Breast Cancer Associated With Carrying a Mutation in BRCA1 or BRCA2
    Malone, Kathleen E.
    Begg, Colin B.
    Haile, Robert W.
    Borg, Ake
    Concannon, Patrick
    Tellhed, Lina
    Xue, Shanyan
    Teraoka, Sharon
    Bernstein, Leslie
    Capanu, Marinela
    Reiner, Anne S.
    Riedel, Elyn R.
    Thomas, Duncan C.
    Mellemkjaer, Lene
    Lynch, Charles F.
    Boice, John D., Jr.
    Anton-Culver, Hoda
    Bernstein, Jonine L.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (14) : 2404 - 2410
  • [27] Breast cancer growth rates in BRCA1/2 mutation carriers
    Bosse, K.
    Gossmann, A.
    Rhiem, K.
    Warm, M.
    Schmutzler, R. K.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [28] Breast cancer prognosis in BRCA1/2 mutation carriers: A case control study
    Arpino, Grazia
    Pensabene, Matilde
    Forestieri, Valeria
    Condello, Caterina
    Sarno, Maria Anna
    Ruocco, Raffaella
    Cerillo, Ivana
    De Angelis, Carmine
    Lauria, Rossella
    Crispo, Anna
    De Placido, Sabino
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [29] Pregnancy after breast cancer in BRCA1/2 mutation carriers
    Jelena Maksimenko
    Arvīds Irmejs
    Jānis Gardovskis
    Hereditary Cancer in Clinical Practice, 20
  • [30] Fear of recurrence among gynaecological cancer survivors: A qualitative study
    Dewi, Selly Kresna
    Afiyanti, Yati
    Rachmawati, Imami Nur
    ENFERMERIA CLINICA, 2021, 31 : S352 - S355